BSX BOSTON SCIENTIFIC CORP
Research report · from SEC EDGAR · close 2026-07-13
$44.65 -0.3%
$66.37B mkt cap
executive summary
BOSTON SCIENTIFIC CORP (BSX) is a $66.37B company. Revenue is $20.07B (+19.9% y/y) at a 14% net margin. It is profitable. Our health score is B (72/100). No major red flags on file. Smart money is buying (3 insider, 4 Congress, 1 funds). It funds itself; low dilution risk.
Revenue (FY)
$20.07B
+19.9% y/y
✓ No major red flags from our filing-based checks.
who's buying
Insider buys / sells
3 / 0
Cash & ST investments
$1.45B
Operating cash flow
$4.53B
Dilution shelf
active shelf
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-13 by stocktools.ai.